InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: skitahoe post# 546991

Saturday, 12/10/2022 7:40:31 PM

Saturday, December 10, 2022 7:40:31 PM

Post# of 693118
Improbable but not impossible, it happens. A full buyout might not be agreeable to NWBO Management at all. But if that is in the cards, which I doubt, then I direct your attention to the meteoric rise of CPXX.. 30x in a matter of weeks on partnership then total buyout about 6 weeks later.
Many 25-30x in 18 month's on no buyout at all. AVXL ARWR and others in the last few years.
I expect NWBO to 25x organically with no partnership or buyout in 18 months or less from now. But prepared to weather further storms for 5 years and accumulate along the way. Approval of DCVax-L is not the end of the fight it will just be as transition from Gorilla warfare to fully Mechanized efforts to occupy the field of Cancer Therapy. Imagine if NWBO sells 5x the market heretofore captured by Keytruda while also expanding Keytruda and others 2-5x all to the detriment of early generation Chemo and Radiation Therapy. NWBO is destined to be a key player in combo with other late generation drugs like Keytruda and Optivo. I envision multiple partnerships. One can think of DCVax -L and Direct as the socket wrench and various combos as the various sockets that are attached to the wrench to turn the tough nuts of heretofore intractable cancers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News